Comparing clinical features of young onset, middle onset and late onset Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 5, 2014, Pages 530-534

  Mehanna, Raja ^a   Moore, Suzanne ^b   Hou, J Gabriel ^b   Sarwar, Aliya I ^b   Lai, Eugene C ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Age at onset; Parkinson; Young onset

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CARBIDOPA; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; ANTIPARKINSON AGENT;

ADULT; AGED; AGITATION; APATHY; ARTICLE; BRADYKINESIA; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIARRHEA; DYSKINESIA; DYSPEPSIA; DYSTONIA; FALLING; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GAIT DISORDER; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA; ONSET AGE; PARKINSON DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGIDITY; SECOND DEGREE RELATIVE; SURVIVAL; TREMOR; VISUAL HALLUCINATION; AGE DISTRIBUTION; COMPARATIVE STUDY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84900022183     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.013     Document Type: Article

References (36)

1. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinsons disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003, 157:1015-1022.
2. Quinn N., Critchley P., Marsden C.D. Young onset Parkinson's disease. Mov Disord 1987, 2:73-91.
3. Yokochi M. Familial juvenile parkinsonism. Eur Neurol 1997, 38(Suppl.1):29-33.
4. Wickremaratchi M.M., Ben-Shlomo Y., Morris H.R. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol 2009, 16:450-456.
5. Wickremaratchi M.M., Perera D., O'Loghlen C., Sastry D., Morgan E., Jones A., et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. JNeurol Neurosurg Psychiatry 2009, 80:805-807.
6. Post B., Speelman J.D., de Haan R.J. Clinical heterogeneity in newly diagnosed Parkinson's disease. JNeurol 2008, 255:716-722. CARPA-study group.
7. Wickremaratchi M.M., Knipe M.D., Sastry B.S., Morgan E., Jones A., Salmon R., et al. The motor phenotype of Parkinson's disease in relation to age at onset. Mov Disord 2011, 26:457-463.
8. Kang G.A., Bronstein J.M., Masterman D.L., Redelings M., Crum J.A., Ritz B. Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord 2005, 20:1133-1142.
9. Knipe M.D., Wickremaratchi M.M., Wyatt-Haines E., Morris H.R., Ben-Shlomo Y. Quality of life in young - compared with late-onset Parkinson's disease. Mov Disord 2011, 26:2011-2018.
10. Arias E. United States Life Tables, 2006. National Vital Statistics Reports 2010, 58(21).
11. Ishihara L.S., Cheesbrough A., Brayne C., Schrag A. Estimated life expectancy of Parkinsons patients compared with the UK population. JNeurol Neurosurg Psychiatry 2007, 78:1304-1309.
12. Forsaa E.B., Larsen J.P., Wentzel-Larsen T., Alves G. What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology 2010, 75:1270-1276.
13. Friedman A. Old-onset Parkinson's disease compared with young onset disease: clinical differences and similarities. Acta Neurol Scand 1994, 89:258-261.
14. Hely M.A., Morris J.G., Reid W.G., O'Sullivan D.J., Williamson P.M., Broe G.A., et al. Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand 1995, 92:455-463.
15. Giovannini P., Piccolo I., Genitrini S., Soliveri P., Girotti F., Geminiani G., et al. Early-onset Parkinson's disease. Mov Disord 1991, 6:36-42.
16. Nagayama H., Hamamoto M., Nito C., Takagi S., Miyazaki T., Katayama Y. Initial symptoms of Parkinson's disease with elderly onset. Gerontology 2000, 46:129-132.
17. Gomez Arevalo G., Jorge R., Garcia S., Scipioni O., Gershanik O. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease. Mov Disord 1997, 12:277-284.
18. Ku S., Glass G.A. Age of Parkinson's disease onset as a predictor for the development of dyskinesia. Mov Disord 2010, 25:1177-1182.
19. Schapira A.H., Olanow C.W. Drug selection and timing of initiation of treatment in early Parkinson's disease. Ann Neurol 2008, 64(Suppl.2):S47-S55.
20. Silver D.E. Early, nondisabling Parkinson's disease: weighing the options for initial therapy. Neurol Clin 2008, 26(Suppl.3):S1-S13.
21. Giladi N., Treves T.A., Paleacu D., Shabtai H., Orlov Y., Kandinov B., et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. JNeural Transm 2000, 107:59-71.
22. Schrag A., Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000, 123:2297-2305.
23. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001, 16:448-458.
24. Kumar N., Van Gerpen J.A., Bower J.H., Ahlskog J.E. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord 2005, 20:342-344.
25. Van Gerpen J.A., Kumar N., Bower J.H., Weigand S., Ahlskog J.E. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol 2006, 63:205-209.
26. García-Ruiz P.J., Del Val J., Fernández I.M., Herranz A. What factors influence motor complications in Parkinson disease?: a 10-year prospective study. Clin Neuropharmacol 2012, 35:1-5.
27. Gershanik O.S., Nygaard T.G. Parkinson's disease beginning before age 40. Adv Neurol 1990, 53:251-258.
28. Kidron D., Melamed E. Forms of dystonia in patients with Parkinson's disease. Neurology 1987, 37:1009-1011.
29. Reider C.R., Halter C.A., Castelluccio P.F., Oakes D., Nichols W.C., Foroud T. Parkinson Study Group. Reliability of reported age at onset for Parkinson's disease. Mov Disord 2003, 18:275-279.
30. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord 2000, 15:819-825.
31. Alves G., Müller B., Herlofson K., HogenEsch I., Telstad W., Aarsland D., et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. JNeurol Neurosurg Psychiatry 2009, 80:851-857.
32. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J., Leenders K.L., Eshuis S., et al. Gender differences in Parkinson's disease. JNeurol Neurosurg Psychiatry 2007, 78:819-824.
33. Solla P., Cannas A., Ibba F.C., Loi F., Corona M., Orofino G., et al. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. JNeurol Sci 2012, 323:33-39.
34. Miller I.N., Cronin-Golomb A. Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord 2010, 25:2695-2703.
35. Rabin M.L., Stevens-Haas C., Havrilla E., Devi T., Kurlan R. Movement disorders in women: a review. Mov Disord. 2014 Feb, 29(2):177-183.
36. Shulman L.M. Gender differences in Parkinson's disease. Gend Med 2007, 4:8-18.